Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice
Joan E. M. van der Lubbe, Johan Verspuij, Jeroen Huizingh, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 25

Showing 25 citing articles:

Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Angelika Wagner, Birgit Weinberger
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 85
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
Carolyn M. Boudreau, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
Brianna L. Bullard, Eric A. Weaver
Vaccines (2021) Vol. 9, Iss. 3, pp. 257-257
Open Access | Times Cited: 49
Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus
Yun Zhang, Cong Xu, Hao Zhang, et al.
Viruses (2019) Vol. 11, Iss. 5, pp. 405-405
Open Access | Times Cited: 48
A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability
Jhanvi Sharma, Kelly M. Shepardson, Laura Johns, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 16, pp. 18211-18224
Closed Access | Times Cited: 47
Protein engineering strategies for rational immunogen design
Timothy M. Caradonna, Aaron G. Schmidt
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 39
Protein engineering and particulate display of B-cell epitopes to facilitate development of novel vaccines
Ziyang Xu, Daniel W. Kulp
Current Opinion in Immunology (2019) Vol. 59, pp. 49-56
Closed Access | Times Cited: 30
Animal Models Utilized for the Development of Influenza Virus Vaccines
Ericka Kirkpatrick Roubidoux, Stacey Schultz‐Cherry
Vaccines (2021) Vol. 9, Iss. 7, pp. 787-787
Open Access | Times Cited: 24
Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
Mark B. Carascal, Rance Derrick N. Pavon, Windell L. Rivera
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
Yulei Li, Peipei Liu, Tianjiao Hao, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
Jenny E. Hernandez‐Davies, Jiin Felgner, Shirin Strohmeier, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
Four‐step approach to efficiently develop capillary gel electrophoresis methods for viral vaccine protein analysis
Lars Geurink, Ewoud van Tricht, Justin Dudink, et al.
Electrophoresis (2020) Vol. 42, Iss. 1-2, pp. 10-18
Open Access | Times Cited: 19
Subdominance in Antibody Responses: Implications for Vaccine Development
Gunnar Lindahl
Microbiology and Molecular Biology Reviews (2020) Vol. 85, Iss. 1
Open Access | Times Cited: 17
A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice
Susan Thrane, Kara-Lee Aves, Ida Uddbäck, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 389-389
Open Access | Times Cited: 16
Using agonists for iNKT cells in cancer therapy
Gavin F. Painter, Olivia K. Burn, Ian F. Hermans
Molecular Immunology (2020) Vol. 130, pp. 1-6
Closed Access | Times Cited: 16
Sixteen capillary electrophoresis applications for viral vaccine analysis
Lars Geurink, Ewoud van Tricht, Debbie van der Burg, et al.
Electrophoresis (2021) Vol. 43, Iss. 9-10, pp. 1068-1090
Open Access | Times Cited: 14
Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination
Boitumelo M. Motsoeneng, Nisha Dhar, Marta C. Nunes, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 6, pp. 1329-1336
Open Access | Times Cited: 1
Incorporation of a Novel CD4+ Helper Epitope Identified from Aquifex aeolicus Enhances Humoral Responses Induced by DNA and Protein Vaccinations
Ziyang Xu, Neethu Chokkalingam, Edgar Tello‐Ruiz, et al.
iScience (2020) Vol. 23, Iss. 8, pp. 101399-101399
Open Access | Times Cited: 13
Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes
Maria K. Smatti, Gheyath K. Nasrallah, Asmaa A. Al Thani, et al.
Vaccine (2019) Vol. 38, Iss. 4, pp. 815-821
Closed Access | Times Cited: 11
Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice
Sergei I. Bazhan, Денис Антонец, Ekaterina V. Starostina, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 448-448
Open Access | Times Cited: 11
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen
Maarten Swart, Harmjan Kuipers, Fin Milder, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice
Laurens P. Kil, Joost Vaneman, Joan E. M. van der Lubbe, et al.
PLoS ONE (2019) Vol. 14, Iss. 11, pp. e0225063-e0225063
Open Access | Times Cited: 3
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
Sathya N. Thulasi Raman, Adrian Zetner, Anwar M. Hashem, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design
Matthias Pauthner, Lars Hangartner
Current topics in microbiology and immunology (2020), pp. 31-87
Closed Access | Times Cited: 3
Going above and Beyond: Using an Attenuated Herpes Viral Vaccine Vector to Elicit Protective Immune Responses Through Neutralizing and Non-neutralizing Functions of Antibodies
Katherine E. Kaugars, Angelo Retamal-Diaz, Anna Paula de Oliveira, et al.
Journal of Cellular Immunology (2022) Vol. 4, Iss. 5
Open Access
Page 1

Scroll to top